Market Research Trending

  1.       In April 2019, VivaQuant, a digital health company, received the U.S. FDA clearance for its RX-1 wearable device that can operate as a Holter monitor 2.       In February 2020, Johnson & Johnson launched a new, virtual clinical study to determine the efficacy of Apple’s iPhone and ECG-enabled smartwatch in reducing the risk of stroke and detecting cases of atrial fibrillation 3.       In November 2019, Bittium Corporation, a Finland-based cardiology, and neurology device company, presented Bittium HolterPlus, a web-based remote cardiac monitoring solution, consisting of a Bittium Faros ECG device and Bittium HolterPlus mobile application, at Medica 2019 4.       In January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient monitoring, received the U.S. FDA clearance for its Continuous ECG platform comprising ...

  1. In April 2019, VivaQuant, a digital health company, gotten the U.S. FDA clearance for its RX- wearable device that can work as a Holter screen   2. In February 2020, Johnson and Johnson dispatched another, virtual clinical investigation to decide the viability of Apple's iPhone and ECG-empowered smartwatch in decreasing the danger of stroke and distinguishing instances of atrial fibrillation 3. In November 2019, Bittium Corporation, a Finland-based cardiology, and nervous system science device company, introduced Bittium HolterPlus, an online far off cardiovascular observing arrangement, comprising of a Bittium Faros ECG device and Bittium HolterPlus portable application, at Medica 2019 4. In January 2020, VivaLNK, a China-based supplier of associated healthcare answers for in-patient and distant patient observing, got the U.S. FDA leeway for its Continuous ECG stage including reusable wearable ECG sensors and related programming advancement unit. 5. In April 20...

  The electrophysiology (EP) devices help in the assessment of electrical motivations of the heart and to ascertain strange pulses. The considerable advancement in the EP advances has upgraded the capacity to focus on the spaces of the heart, sustaining that prompts atrial fibrillation (AF). Electrophysiology innovation has been advancing the previous few years rapidly with new removal techniques to progress atrial fibrillation (AF) medicines, decreased symptomatic checking frameworks, and new implantable beat the executives devices that are making methods considerably less intrusive. Electrophysiology devices market is expected to fill in the conjecture time frame inferable from driving variables like rising predominance of atrial fibrillation, mechanical progressions, developing focal point of significant players to consolidate innovations to extend their topographical presence, and developing cardiovascular sicknesses across the globe. In addition, rising medical services cons...